文献速递神经肿瘤

低剂量头照射后威胁视力的脑膜瘤视觉结局:头癣作为范例

Visual outcomes of sight threatening radiation-induced meningiomas after low-dose head irradiation: tinea capitis as a paradigm.
PubMed 文献 · J Neurooncol · 2026-07-07

本研究回顾性纳入289例视神经或颅内视觉通路旁脑膜瘤成人患者,其中31例(10.7%)有头癣放疗史。暴露组就诊时中位BCVA为0.1 LogMAR,51.61%存在视力丧失,末次随访BCVA降至0.23 LogMAR。与114例无放疗史视觉丧失患者比较,就诊时及随访视觉特征均无统计学显著差异。

要点

  • 低剂量头照射后视觉通路脑膜瘤的视觉表现与无放疗史者无显著差异。
  • 暴露组约半数就诊时已有视力丧失,随访视力进一步下降。
  • 头癣放疗史患者占本队列10.7%,提示需关注该人群视觉监测。

核心结论

  • 低剂量儿童期头照射后视觉通路脑膜瘤患者与无放疗史患者在临床表现或视觉预后上未检测到统计学显著差异。

研究设计与样本

  • 回顾性队列研究,纳入2004至2023年间289例视神经或颅内视觉通路旁脑膜瘤成人患者,分为放疗暴露组与未暴露组。

主要发现

  • 289例中31例(10.7%)有头癣放疗史。
  • 暴露组就诊时中位BCVA为0.1 LogMAR(IQR 0.1-0.6),中位色觉为100%(IQR 64.5%-100%),9例(29%)视野正常。
  • 暴露组16例(51.61%)存在视力丧失,末次随访BCVA降至中位0.23 LogMAR(IQR 0.1-1.46)。
  • 与114例无放疗史脑膜瘤所致视力丧失患者比较,就诊时及随访视觉特征均无统计学显著差异。

临床怎么用

  • 对低剂量头照射史(如头癣放疗)的视觉通路脑膜瘤患者,可按无放疗史患者的视觉评估与随访原则进行管理。
  • 因低剂量颅照射仍用于甲状腺眼病等疾病,本研究结果对该类人群的视觉监测具有参考意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the visual characteristics and prognosis of vision-threatening meningiomas following low dose head radiation and compare them to those of primary unexposed meningiomas. METHODS: A retrospective cohort of adults with meningiomas adjacent to the optic nerves or intracranial visual pathways was categorized into radiation-exposed and unexposed meningiomas. Data collected included demographics, visual biomarkers at presentation and at final follow-up, including Visual Acuity (VA), color vision (CV), Visual Field (VF) and peripapillary Retinal Nerve Fiber Layer (RNFL) thickness via Optical coherence tomography (OCT). Comparative analyses were performed between radiation-exposed and unexposed cohorts. RESULTS: 289 eligible patients seen between 2004 and 2023 were included, out of which 31 (10.7%) had undergone tinea capitis radiation. At presentation, patients exhibited a median BCVA of 0.1 LogMAR [IQR 0.1-0.6], median CV of 100% [IQR 64.5%-100%], and 9 (29%) had normal visual fields. Notably, 16 (51.61%) experienced visual loss. Their BCVA decreased at final follow-up, to median 0.23 [IQR 0.1-1.46]. Comparative analysis with 114 radiation-naïve patients with meningioma-induced visual loss revealed no statistically significant disparities in visual characteristics at presentation or at follow-up. CONCLUSIONS: No statistically significant differences in clinical presentation or visual prognosis were detected between patients with visual pathway meningiomas exposed to low-dose childhood radiation and radiation-naïve patients. Since low-dose cranial irradiation continues to be widely used for conditions such as thyroid eye disease, our findings are relevant beyond the specific context of tinea capitis.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Palevski D, Stiebel-Kalish H, Bialer OY, et al. Visual outcomes of sight threatening radiation-induced meningiomas after low-dose head irradiation: tinea capitis as a paradigm. J Neurooncol. 2026. PMID: 42414596. doi:10.1007/s11060-026-05696-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。